Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-072511
Filing Date
2015-09-29
Accepted
2015-09-29 20:52:36
Documents
1
Period of Report
2015-09-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3623
  Complete submission text file 0001209191-15-072511.txt   5474
Mailing Address 8910 UNIVERSITY CENTER DRIVE SUITE 700 San Diego CA 92122
Business Address 8910 UNIVERSITY CENTER DRIVE SUITE 700 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Issuer) CIK: 0001394319 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address OTEMACHI FIRST SQUARE, WEST TOWER 11F 1-5-1 OTEMACHI CHIYODA-KU, TOKYO 100-0004 M0 100-0004
Business Address OTEMACHI FIRST SQUARE, WEST TOWER 11F 1-5-1 OTEMACHI CHIYODA-KU, TOKYO 100-0004 M0 100-0004 81-3-5223-7008
JAFCO Super V3 Investment Limited Partnership (Reporting) CIK: 0001590442 (see all company filings)

State of Incorp.: M0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36818 | Film No.: 151132030